Cargando…
Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis
Osteoporosis is a systemic metabolic bone disease with characteristics of bone loss and microstructural degeneration. The personal and societal costs of osteoporosis are increasing year by year as the ageing of population, posing challenges to public health care. Homing disorders, impaired capabilit...
Autores principales: | Jiang, Yuhe, Zhang, Ping, Zhang, Xiao, Lv, Longwei, Zhou, Yongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791182/ https://www.ncbi.nlm.nih.gov/pubmed/33210341 http://dx.doi.org/10.1111/cpr.12956 |
Ejemplares similares
-
SIRT6 promotes osteogenic differentiation of mesenchymal stem cells through BMP signaling
por: Zhang, Ping, et al.
Publicado: (2017) -
LRRC15 promotes osteogenic differentiation of mesenchymal stem cells by modulating p65 cytoplasmic/nuclear translocation
por: Wang, Yuejun, et al.
Publicado: (2018) -
Exosomes derived from miR‐375‐overexpressing human adipose mesenchymal stem cells promote bone regeneration
por: Chen, Si, et al.
Publicado: (2019) -
Asymmetrical methyltransferase PRMT3 regulates human mesenchymal stem cell osteogenesis via miR-3648
por: Min, Zhang, et al.
Publicado: (2019) -
Advances in the application of mesenchymal stem cells, exosomes, biomimetic materials, and 3D printing in osteoporosis treatment
por: He, Xiao-Yu, et al.
Publicado: (2021)